BioBoard
•  Two World-renowned Cancer Experts Relocate to Singapore
•  Genome Institute of Singapore Develops Breakthrough Technology
•  GSK to Build State-of-the-art R&D Facility in Tuas, Singapore
•  Roche Gives Vietnam the Right to Make Tamiflu
•  Dr Reddy's Acquires Roche's Bulk Drug Factory in Mexico
•  World Bank Creates $500M Bird Flu Fund
•  The United Nations Announces the Anti-Tabacco Convention
•  IBM Joins in Cancer Research
•  Japan to Cull 170,000 More Chickens
•  Thailand to Produce Generic Treatment for Bird Flu
•  US Health and Human Sciences and People's Republic of China Partner to Combat Infectious Diseases

Special Feature
•  AmpliChip CYP450 Test - An Important Step Forward in Making Personalized Medicine a Reality
•  Automating and Miniaturizing Molecular Diagnostic on a BioChip
•  Blood Pressure Monitoring: State-Of-the-Art: BPro
•  Nanobiotechnologies to Provide a Portable Genetic Biosensor Device
•  Inzign - A Singapore-based Company with Biomedical Device Contract Manufacturing Ambitions
•  Technical Paper on Microfl uidic Devices - Cell Separation Technology

Industry Watch
•  Australia's C3 Signs Korean Licensing Deal for Burn Treatment
•  CyGenics Takes 51% Equity in BioCell Pty Ltd
•  BresaGen Expands into Mammalian Cell-Derived Products
•  Japan's Bioventures - Japan Tissue Engineering Co Ltd (J-TEC)
•  Proacta Nears Multibillion-Dollar Goal with PR104
•  MerLion Pharmaceuticals Collaborates with the US National Cancer Institute
•  Rockeby Biomed Launched Rapid Test Kits to detect Avian Flu

Research Findings
•  IMCB Team Identifies 'missing' Protein that Triggers Mutation in Cancer Cell

Alternative Medicine
•  Cordyceps sinensis - a Traditional Chinese Medicine Known as Winter-worm Summer-grass

General News
•  Singapore Sets Up Four New Translational Research Initiatives

Conference Calendar